Home » Biotech and Technology Stocks Rally, Is It A Breakout or Fakeout?

stock market S&P 500

Biotech and Technology Stocks Rally, Is It A Breakout or Fakeout?

[widget id=”text-23″]

Biotech and Technology Stocks Rally, Is It A Breakout or Fakeout?

Unlock Deeper Insights with Exclusive Member-Only Video Content on The Market Chronicles YouTube Channel – Just $34.99/Month

Join this channel to get access to perks:https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/joinPlease check out my content on Substack and Seeking Alpha:https://www.themarketchronicle.com/https://seekingalpha.com/affiliate_link/Youtube81624#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment. 9:33
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuZk42R3ZSNkwtSjQ

Job Report Impacts

October 4, 2024 2:08 PM

Join this channel to get access to perks:https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/joinPlease check out my content on Substack and Seeking Alpha:https://www.themarketchronicle.com/https://seekingalpha.com/affiliate_link/Youtube81624#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment. 40:47
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEua2FQOWNyN0FZWFE

NFP Live Zoom Replay 10.4.24

October 4, 2024 9:07 AM

Join this channel to get access to perks:https://www.youtube.com/channel/UCIIr1ooRsSukPL7rKNr0VHQ/joinPlease check out my content on Substack and Seeking Alpha:https://www.themarketchronicle.com/https://seekingalpha.com/affiliate_link/Youtube81624#sp500 #stocks #stockmarket #cpi #fed #qqq #spy #rates Charts used with the permission of Bloomberg Finance L.P. This report contains independent commentary to be used for informational and educational purposes only. Michael Kramer is a member and investment adviser representative with Mott Capital Management. Mr. Kramer is not affiliated with this company and does not serve on the board of any related company that issued this stock. All opinions and analyses presented by Michael Kramer in this analysis or market report are solely Michael Kramer’s views. Readers should not treat any opinion, viewpoint, or prediction expressed by Michael Kramer as a specific solicitation or recommendation to buy or sell a particular security or follow a particular strategy. Michael Kramer’s analyses are based upon information and independent research that he considers reliable, but neither Michael Kramer nor Mott Capital Management guarantees its completeness or accuracy, and it should not be relied upon as such. Michael Kramer is not under any obligation to update or correct any information presented in his analyses. Mr. Kramer’s statements, guidance, and opinions are subject to change without notice. Past performance is not indicative of future results. Neither Michael Kramer nor Mott Capital Management guarantees any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment commentary presented in this analysis. Strategies or investments discussed may fluctuate in price or value. Investments or strategies mentioned in this analysis may not be suitable for you. This material does not consider your particular investment objectives, financial situation, or needs and is not intended as a recommendation appropriate for you. You must make an independent decision regarding investments or strategies in this analysis. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Before acting on information in this analysis, you should consider whether it is suitable for your circumstances and strongly consider seeking advice from your own financial or investment adviser to determine the suitability of any investment. 12:52
YouTube Video VVVNT0lJcjFvb1JzU3VrUEw3cktOcjBWSFEuUUJqT09FMHhhdjA

Jobs Report Preview

October 3, 2024 2:43 PM

Load More... Subscribe

[widget id=”text-21″]

Biotech and Technology stocks both showed a little bit more life today, then they have in past days. Should this trend continue tomorrow, it would be a good sign for the stock market as a whole.

[widget id=”text-16″]

S&P 500

The stock market continues to be extremely volatile, with another day of wild price action. I think I wrote this last week, but it makes trading this market nearly impossible. I’m glad I do not trade the market, and only use a buy and hold strategy, easier to manage, and less stressful. The S&P 500 lows reached 2,700 today, by the end of the day we made a round trip and finished lower by only 1 point, go figure.  The volatility remains too dangerous to try to time anything these days. The sad part, I think it is here to stay for some time, and we should get used to it.

stock market S&P 500

[widget id=”wordads_sidebar_widget-41″]

[widget id=”text-19″]

Biotech Stocks

The NASDAQ Biotech ETF (IBB) closed today just a hair above $111.50, at $111.80. For me, that is not enough to say it broke out. You need to watch tomorrow for a follow through. The group needs to continue higher and manage to rise significantly above $112. Also, I want to see this group meaningfully outperform the major averages. If we get those two pieces tomorrow, I become much more constructive on the group. But to this point, I’m not convinced.

biotech

The iShares Biotech ETF (XBI) had a much sharper rise, but again,  I want to see a meaningful follow through tomorrow.

biotech

[widget id=”text-22″]

Technology Stocks

The technology ETF (XLK) is making a move towards resistance again, and all I can say is that this time it better rise above $69.25. We do not want this group failing three times at resistance.

technology

If these two sectors can start working, then I think I would become more constructive on the stock market. For now, I think these moves need to continue to be considered suspect. The way the stock market whips around these days, it makes it impossible to sit back and just ride a trend, because that trend can change direction very quickly.

That’s gonna be it for today. Let’s see what tomorrow brings.

[widget id=”wordads_sidebar_widget-41″]

[widget id=”text-22″]

Mott Capital’s Reading The Markets – An In-depth Global Macro Stock Market Commentary – In Video Format – See How Michael Dissects The Markets

Just $200 Per Year – Get Your Free 2 Week Trial

Recent Videos:

Tech And Biotech Look Weak, Plus Subscriber Mailbag

What The Heck Happened

Breaking Down Acadia’s Results, Exploring Trends In Chips Stocks

Stocks In Rally Mode, More To Come

Crazy Market Reaction Following Fed Minutes, Plus Subscriber Mail Bag

Subscriber Mailbag, Plus Market Rundown

Free Articles Written By Mike:

Why Biotech Stocks Face Steep Declines Ahead

Netflix Stock Is Poised For An 11% Plunge

Why Salesforce’s Record Stock Gains May Not Last

4 Red Flags For Technology Stocks

Biotech Stock Nektar May Be Ripe For A Sharp Pullback

Macy’s May Fall 18% as Option Traders Turn Bears

Micron May Rise 12% As Analysts Grow More Bullish

Why Amazon’s Stock May Continue To Outperform Alibaba’s

AMD May Fall 17% as Bearish Option Volume Soars

Join our 2,666 Daily Subscribers And Get This Commentary In Your E-Mail! Subscribe

-OR-

[vc_tweetmeme type=”follow” follow_user=”michaelmottcm” show_followers_count=”true” large_button=”true”]

Photo credit via Flickr

 

Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future.

© 2018 Mott Capital Management, LLC.  Use, publication or reproduction in any media prohibited without the permission of the copyright holder.

Tags: #sp500 #biotech #technology #stocks #sp500

 

 

Add your email to The Market Chronicles' growing list of daily readers. A FREE market commentary on the trading day's most critical and least apparent events!

Add your email to The Market Chronicles' growing list of daily readers. A FREE market commentary on the trading day's most critical and least apparent events!